What I Read This Week...

Drug companies race to fix muscle mass loss caused by Ozempic, doctors discover a new cause for women's autoimmune conditions, and Adam Neumann tries to buy back WeWork

Read our AI Deep Dive Watch All-In E165 Listen to Our Discussion About AI Hardware Caught My Eye… Drug companies, nutrition startups and gyms are racing to offer solutions to muscle mass loss caused by weight-loss drugs like Ozempic. While GLP-1s, the current class of weight-loss drugs offered by companies like Novo Nordisk, can help patients rapidly lose weight and steer off cravings, much of this weight loss is often in the form of lean muscle mass which risks accelerating frailty in older patients. While drug companies are trying to develop solutions to this issue, doctors are…

related reading

• Why Does Ozempic Cure All Diseases?astralcodexten.com
• Articles — Asimov Presspress.asimov.com
• The Ozempocalypse Is Nigh - by Scott Alexanderastralcodexten.com
• The Drug That Made Me Want Lessbylinebyline.com
• The Worst Argument Against Ozempic - Cremieux Recueilcremieux.xyz
• Join Delilah: Personalized Weight Management for Womenjoindelilah.com
• Ro - Weight loss, better sex, fuller hair, improved skin and more onlinero.co
• Semaglutidonomicsastralcodexten.com
• The Other Ozempic Revolution - The Atlantictheatlantic.com
• The Promise and Impact of the Next Generation of Weight Loss Drugsmetaculus.com
• How to keep weight off after obesity drugsnature.com
• If GLP-1 Drugs Are Good For Everything, Should We All Be on Them?derekthompson.org